nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—MTOR—leg—osteoarthritis	0.141	0.315	CbGeAlD
Pimecrolimus—MTOR—forelimb—osteoarthritis	0.14	0.313	CbGeAlD
Pimecrolimus—MTOR—hindlimb—osteoarthritis	0.126	0.282	CbGeAlD
Pimecrolimus—MTOR—HSF1-dependent transactivation—CAMK2B—osteoarthritis	0.0239	0.0431	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—SOX9—osteoarthritis	0.0216	0.039	CbGpPWpGaD
Pimecrolimus—MTOR—tendon—osteoarthritis	0.0211	0.0474	CbGeAlD
Pimecrolimus—FKBP1A—tendon—osteoarthritis	0.019	0.0426	CbGeAlD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—osteoarthritis	0.0168	0.0303	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular response to heat stress—CAMK2B—osteoarthritis	0.0154	0.0278	CbGpPWpGaD
Pimecrolimus—MTOR—IFN-gamma pathway—CAMK2B—osteoarthritis	0.014	0.0252	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—osteoarthritis	0.0124	0.0223	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—TNFSF11—osteoarthritis	0.0123	0.0222	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—COL10A1—osteoarthritis	0.0119	0.0215	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—TNFRSF11B—osteoarthritis	0.0115	0.0207	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—CTSK—osteoarthritis	0.0115	0.0207	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—COL2A1—osteoarthritis	0.0115	0.0207	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—osteoarthritis	0.0114	0.0205	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—osteoarthritis	0.011	0.0199	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—osteoarthritis	0.0106	0.0192	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—osteoarthritis	0.00993	0.0179	CbGpPWpGaD
Pimecrolimus—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.00947	0.0171	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CAMK2B—osteoarthritis	0.00918	0.0166	CbGpPWpGaD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—osteoarthritis	0.00896	0.0162	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—MMP13—osteoarthritis	0.00883	0.0159	CbGpPWpGaD
Pimecrolimus—FKBP1A—ALK1 signaling events—TGFB1—osteoarthritis	0.00838	0.0151	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—osteoarthritis	0.0071	0.0128	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—IL1RN—osteoarthritis	0.00692	0.0125	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL1A—osteoarthritis	0.00617	0.0111	CbGpPWpGaD
Pimecrolimus—MTOR—LKB1 signaling events—ESR1—osteoarthritis	0.00607	0.011	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—osteoarthritis	0.00591	0.0107	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—BMP2—osteoarthritis	0.00581	0.0105	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—COL9A2—osteoarthritis	0.00562	0.0101	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—COL9A1—osteoarthritis	0.00546	0.00985	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—MCF2L—osteoarthritis	0.00534	0.00963	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—SMAD3—osteoarthritis	0.00516	0.00931	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—LEP—osteoarthritis	0.00504	0.0091	CbGpPWpGaD
Pimecrolimus—MTOR—Type II diabetes mellitus—TNF—osteoarthritis	0.00503	0.00908	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—osteoarthritis	0.00481	0.00869	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—MMP1—osteoarthritis	0.00472	0.00853	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—osteoarthritis	0.00467	0.00843	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—BMP2—osteoarthritis	0.00451	0.00814	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—osteoarthritis	0.00436	0.00787	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—LEP—osteoarthritis	0.00436	0.00787	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—IGF1—osteoarthritis	0.00432	0.00779	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—ESR1—osteoarthritis	0.00421	0.0076	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—osteoarthritis	0.0042	0.00759	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—LEP—osteoarthritis	0.00408	0.00736	CbGpPWpGaD
Pimecrolimus—MTOR—IFN-gamma pathway—IL1B—osteoarthritis	0.00406	0.00732	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—CXCL8—osteoarthritis	0.00394	0.00711	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—ESR1—osteoarthritis	0.00389	0.00702	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL1A—osteoarthritis	0.00381	0.00687	CbGpPWpGaD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—osteoarthritis	0.00379	0.00685	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—osteoarthritis	0.00364	0.00658	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—PTGS2—osteoarthritis	0.00346	0.00624	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—CXCL8—osteoarthritis	0.00335	0.00605	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00328	0.00591	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CAMK2B—osteoarthritis	0.00327	0.0059	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—FMOD—osteoarthritis	0.00326	0.00589	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL1B—osteoarthritis	0.00322	0.0058	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL1B—osteoarthritis	0.00311	0.00561	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoarthritis	0.00308	0.00555	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—MMP9—osteoarthritis	0.00303	0.00547	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—IGF1—osteoarthritis	0.00294	0.0053	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—FN1—osteoarthritis	0.00294	0.0053	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IHH—osteoarthritis	0.00291	0.00525	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—IGF1—osteoarthritis	0.00286	0.00516	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00284	0.00512	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—IL1B—osteoarthritis	0.0026	0.00469	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.00259	0.00467	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.00257	0.00465	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TGFB1—osteoarthritis	0.0025	0.00451	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.00242	0.00436	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00241	0.00434	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00235	0.00424	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TNF—osteoarthritis	0.00233	0.00421	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—MMP9—osteoarthritis	0.00224	0.00404	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00222	0.00401	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—ESR1—osteoarthritis	0.00221	0.00399	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—IL6—osteoarthritis	0.00221	0.00399	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—TGFB1—osteoarthritis	0.00218	0.00394	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFBI—osteoarthritis	0.00217	0.00392	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00207	0.00374	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IHH—osteoarthritis	0.00204	0.00368	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MCF2L—osteoarthritis	0.00204	0.00368	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00199	0.00358	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL6—osteoarthritis	0.00188	0.0034	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GSTO1—osteoarthritis	0.00188	0.00338	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00184	0.00333	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—FMOD—osteoarthritis	0.00184	0.00331	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL1A—osteoarthritis	0.00182	0.00329	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—BGN—osteoarthritis	0.00182	0.00328	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CTSK—osteoarthritis	0.00175	0.00315	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00172	0.00311	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.0017	0.00307	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CTSK—osteoarthritis	0.00168	0.00303	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IHH—osteoarthritis	0.00164	0.00295	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00159	0.00286	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00154	0.00278	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—COL9A2—osteoarthritis	0.0015	0.0027	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00148	0.00267	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—COL9A1—osteoarthritis	0.00145	0.00262	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-mediated signalling—IL6—osteoarthritis	0.00138	0.00248	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.00137	0.00247	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00135	0.00244	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events—IL6—osteoarthritis	0.00134	0.00242	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HSPA5—osteoarthritis	0.00134	0.00241	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.00133	0.0024	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—IL6—osteoarthritis	0.00129	0.00233	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—IL6—osteoarthritis	0.00129	0.00233	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFBI—osteoarthritis	0.00122	0.0022	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.00116	0.0021	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IHH—osteoarthritis	0.00115	0.00207	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MCF2L—osteoarthritis	0.00115	0.00207	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.00115	0.00207	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—IL6—osteoarthritis	0.00108	0.00195	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by Insulin receptor—IL6—osteoarthritis	0.00107	0.00194	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GSTO1—osteoarthritis	0.00105	0.0019	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—BGN—osteoarthritis	0.00102	0.00184	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CAMK2B—osteoarthritis	0.00102	0.00184	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTSK—osteoarthritis	0.00102	0.00184	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—BMP2—osteoarthritis	0.000995	0.0018	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CXCL8—osteoarthritis	0.00099	0.00179	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—osteoarthritis	0.000918	0.00166	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SMAD3—osteoarthritis	0.000891	0.00161	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000879	0.00159	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—osteoarthritis	0.000865	0.00156	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—COL9A2—osteoarthritis	0.000841	0.00152	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—osteoarthritis	0.000826	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—osteoarthritis	0.000822	0.00148	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—osteoarthritis	0.000818	0.00148	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—COL9A1—osteoarthritis	0.000817	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—osteoarthritis	0.000814	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—osteoarthritis	0.000814	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HSPA5—osteoarthritis	0.00081	0.00146	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1RN—osteoarthritis	0.000788	0.00142	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000766	0.00138	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—osteoarthritis	0.000766	0.00138	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—osteoarthritis	0.000766	0.00138	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—osteoarthritis	0.000759	0.00137	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000752	0.00136	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—osteoarthritis	0.000749	0.00135	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP3—osteoarthritis	0.00069	0.00124	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000678	0.00122	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SMAD3—osteoarthritis	0.000624	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1A—osteoarthritis	0.000567	0.00102	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—BMP2—osteoarthritis	0.00056	0.00101	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—osteoarthritis	0.000556	0.001	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LEP—osteoarthritis	0.000534	0.000963	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—osteoarthritis	0.000522	0.000942	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—osteoarthritis	0.000522	0.000941	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ESR1—osteoarthritis	0.000509	0.000919	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—FN1—osteoarthritis	0.000503	0.000908	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SMAD3—osteoarthritis	0.000501	0.000905	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—osteoarthritis	0.000474	0.000856	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF1—osteoarthritis	0.000441	0.000796	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000408	0.000736	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP3—osteoarthritis	0.000388	0.0007	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—osteoarthritis	0.000377	0.000681	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—osteoarthritis	0.000355	0.00064	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SMAD3—osteoarthritis	0.000351	0.000634	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000332	0.0006	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—osteoarthritis	0.000321	0.000579	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—osteoarthritis	0.0003	0.000542	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—osteoarthritis	0.000297	0.000537	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—osteoarthritis	0.000296	0.000534	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—osteoarthritis	0.000294	0.00053	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ESR1—osteoarthritis	0.000287	0.000517	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—osteoarthritis	0.000284	0.000513	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—FN1—osteoarthritis	0.000283	0.000511	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—osteoarthritis	0.000264	0.000477	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF1—osteoarthritis	0.000248	0.000448	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000234	0.000423	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—BGN—osteoarthritis	0.000227	0.000409	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—osteoarthritis	0.000212	0.000383	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—osteoarthritis	0.000199	0.00036	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—osteoarthritis	0.000199	0.00036	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—osteoarthritis	0.00018	0.000326	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—osteoarthritis	0.000173	0.000313	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—osteoarthritis	0.00016	0.000289	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—osteoarthritis	0.000149	0.000268	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—osteoarthritis	0.000112	0.000202	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—osteoarthritis	6.52e-05	0.000118	CbGpPWpGaD
